All News #Library
Biotech
AlloVir finds new identity via eye disease biotech merger
11 Nov 2024 //
FIERCE BIOTECH
AlloVir lays off 95% of staffers after shuttering PhIII cell therapy trials
05 Jan 2024 //
ENDPTS
AlloVir Presents Positive Final Results From A PII Trial Evaluating Posoleucel
05 Jun 2023 //
BUSINESSWIRE
AlloVir`s cell therapy tackles virus in kidney transplant trial
16 Feb 2023 //
FIERCE BIOTECH
AlloVir Announces Final Results from Phase 2 Study of Posoleucel with BK Viremia
15 Feb 2023 //
BUSINESSWIRE
AlloVir Announces Plans to Complete Enrollment in Three PIII Posoleucel Studies
09 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support